Adebrelimab (SHR-1316) in Combination With Chemotherapy as Perioperative Treatment in Patients With Resectable Stage II to III NSCLCs: An Open-Label, Multicenter, Phase 1b Trial
- Resource Type
- Article
- Source
- In
Journal of Thoracic Oncology February 2023 18(2):194-203 - Subject
- Language
- ISSN
- 1556-0864